Hesham Mohamed Korashy

19PUBLICATIONS
23CO-AUTHORS
Disease surveillanceCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsCancer geneticsCell development, proliferation and death
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|Sep 07, 2026
Endothelial and Vascular Toxicity Signals Associated With Doxorubicin: A Pharmacovigilance Analysis of the FDA Adverse Event Reporting System (FAERS) Database.

|Nov 13, 2025
The role of immune checkpoints in modulating cancer stem cells anti-tumor immune responses: implications and perspectives in cancer therapy.

Ola J Hussein, Menatallah Rayan, Tasnim R Matarid

|Mar 14, 2024
Apabetalone (RVX-208): A Potential Epigenetic Therapy for the Treatment of Cardiovascular, Renal, Neurological, Viral, and Cancer Disorders.

Hevna Dhulkifle, Mohammad Issam Diab, Majed Algonaiah

|Mar 06, 2024
Unlocking the secrets: exploring the influence of the aryl hydrocarbon receptor and microbiome on cancer development.

Menatallah Rayan, Tahseen S Sayed, Ola J Hussein

|Mar 11, 2023
Sestrin2 as a Protective Shield against Cardiovascular Disease.

Muhammad Ammar Zahid, Shahenda Salaheldin Abdelsalam, Hicham Raïq

|Mar 06, 2023
6-Formylindolo(3,2-b)carbazole Dampens Inflammation and Reduces Endotoxin-Induced Kidney Injury via Nrf2 Activation.

Hevna Dhulkifle, Tahseen S Sayed, Hanan H Abunada

Pageof 4

Frequent Collaborators

7 joint publications

Abdelali Agouni

3 joint publications

Zaid H Maayah

2 joint publications

Ali Alhoshani

2 joint publications

Hevna Dhulkifle